Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Reply to Lindsey, Höschler and de Silva.

Matrajt L, Halloran ME, Antia R.

Clin Infect Dis. 2019 Aug 14. pii: ciz774. doi: 10.1093/cid/ciz774. [Epub ahead of print] No abstract available.

PMID:
31412101
2.

Networks of face-to-face social contacts in Niakhar, Senegal.

Potter GE, Wong J, Sugimoto J, Diallo A, Victor JC, Neuzil K, Halloran ME.

PLoS One. 2019 Aug 6;14(8):e0220443. doi: 10.1371/journal.pone.0220443. eCollection 2019.

3.

Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands.

Feldstein LR, Ellis EM, Rowhani-Rahbar A, Hennessey MJ, Staples JE, Halloran ME, Weaver MR.

PLoS Negl Trop Dis. 2019 Jul 19;13(7):e0007563. doi: 10.1371/journal.pntd.0007563. eCollection 2019 Jul.

4.

Design of vaccine efficacy trials during public health emergencies.

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaat0360. doi: 10.1126/scitranslmed.aat0360. Review.

5.

Comment on Laber et al.

Halloran ME, Hudgens MG.

J R Stat Soc Ser C Appl Stat. 2018 Aug;67(4):776. Epub 2018 Jul 18. No abstract available.

6.

Reply to Skowronski and De Serres.

Ortiz JR, Sugimoto JD, Neuzil KM, Halloran ME, Victor JC.

Clin Infect Dis. 2019 May 6. pii: ciz352. doi: 10.1093/cid/ciz352. [Epub ahead of print] No abstract available.

PMID:
31056688
7.

Successes and failures of the live-attenuated influenza vaccine: can we do better?

Matrajt L, Halloran ME, Antia R.

Clin Infect Dis. 2019 May 6. pii: ciz358. doi: 10.1093/cid/ciz358. [Epub ahead of print]

PMID:
31056675
8.

Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design.

Basta NE, Halloran ME.

Am J Epidemiol. 2019 Jun 1;188(6):987-990. doi: 10.1093/aje/kwz043.

9.

Effects of infection history on dengue virus infection and pathogenicity.

Tsang TK, Ghebremariam SL, Gresh L, Gordon A, Halloran ME, Katzelnick LC, Rojas DP, Kuan G, Balmaseda A, Sugimoto J, Harris E, Longini IM Jr, Yang Y.

Nat Commun. 2019 Mar 18;10(1):1246. doi: 10.1038/s41467-019-09193-y.

10.

Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh.

Schwartz LM, Zaman K, Yunus M, Basunia AH, Faruque ASG, Ahmed T, Rahman M, Sugimoto JD, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC.

Clin Infect Dis. 2019 Feb 12. doi: 10.1093/cid/ciz133. [Epub ahead of print]

PMID:
30753368
11.

Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial.

Diallo A, Diop OM, Diop D, Niang MN, Sugimoto JD, Ortiz JR, Faye EHA, Diarra B, Goudiaby D, Lewis KDC, Emery SL, Zangeneh SZ, Lafond KE, Sokhna C, Halloran ME, Widdowson MA, Neuzil KM, Victor JC.

Clin Infect Dis. 2019 Jan 28. doi: 10.1093/cid/ciz066. [Epub ahead of print]

PMID:
30689757
12.

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.

Pasin C, Halloran ME, Gilbert PB, Langevin E, Ochiai RL, Pitisuttithum P, Capeding MR, Carrasquilla G, Frago C, Cortés M, Chambonneau L, Moodie Z.

PLoS One. 2018 Dec 13;13(12):e0207878. doi: 10.1371/journal.pone.0207878. eCollection 2018.

13.

Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016).

Pavía-Ruz N, Barrera-Fuentes GA, Villanueva-Jorge S, Che-Mendoza A, Campuzano-Rincón JC, Manrique-Saide P, Rojas DP, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gómez-Dantés H.

PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006748. doi: 10.1371/journal.pntd.0006748. eCollection 2018 Nov.

14.

Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up.

Rojas DP, Barrera-Fuentes GA, Pavia-Ruz N, Salgado-Rodriguez M, Che-Mendoza A, Manrique-Saide P, Vazquez-Prokopec GM, Halloran ME, Longini IM, Gomez-Dantes H.

PLoS Negl Trop Dis. 2018 Nov 21;12(11):e0006847. doi: 10.1371/journal.pntd.0006847. eCollection 2018 Nov.

15.

Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic.

Sun K, Zhang Q, Pastore-Piontti A, Chinazzi M, Mistry D, Dean NE, Rojas DP, Merler S, Poletti P, Rossi L, Halloran ME, Longini IM Jr, Vespignani A.

BMC Med. 2018 Oct 18;16(1):195. doi: 10.1186/s12916-018-1185-5.

16.

Optimizing and evaluating biomarker combinations as trial-level general surrogates.

Gabriel EE, Sachs MC, Daniels MJ, Halloran ME.

Stat Med. 2019 Mar 30;38(7):1135-1146. doi: 10.1002/sim.7996. Epub 2018 Oct 10.

PMID:
30306600
17.

Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks.

Zarnitsyna VI, Bulusheva I, Handel A, Longini IM, Halloran ME, Antia R.

PLoS One. 2018 Jun 26;13(6):e0199674. doi: 10.1371/journal.pone.0199674. eCollection 2018.

18.

Forecasting the effectiveness of indoor residual spraying for reducing dengue burden.

Hladish TJ, Pearson CAB, Patricia Rojas D, Gomez-Dantes H, Halloran ME, Vazquez-Prokopec GM, Longini IM.

PLoS Negl Trop Dis. 2018 Jun 25;12(6):e0006570. doi: 10.1371/journal.pntd.0006570. eCollection 2018 Jun.

19.

Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China.

Tsang TK, Chen TM, Longini IM Jr, Halloran ME, Wu Y, Yang Y.

Epidemiology. 2018 Sep;29(5):675-683. doi: 10.1097/EDE.0000000000000855.

PMID:
29847497
20.

DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.

Dean NE, Halloran ME, Longini IM.

Ann Appl Stat. 2018 Mar;12(1):330-347. doi: 10.1214/17-AOAS1095. Epub 2018 Mar 9.

21.

Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico.

Bisanzio D, Dzul-Manzanilla F, Gomez-Dantés H, Pavia-Ruz N, Hladish TJ, Lenhart A, Palacio-Vargas J, González Roldan JF, Correa-Morales F, Sánchez-Tejeda G, Kuri Morales P, Manrique-Saide P, Longini IM, Halloran ME, Vazquez-Prokopec GM.

PLoS Negl Trop Dis. 2018 Mar 15;12(3):e0006298. doi: 10.1371/journal.pntd.0006298. eCollection 2018 Mar.

22.

Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial.

Fong Y, Halloran ME, Park JK, Marks F, Clemens JD, Chao DL.

BMC Infect Dis. 2018 Feb 20;18(1):84. doi: 10.1186/s12879-018-2981-4.

23.

Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico.

Pavía-Ruz N, Diana Patricia Rojas, Salha Villanueva, Granja P, Balam-May A, Longini IM, Halloran ME, Manrique-Saide P, Gómez-Dantés H.

Am J Trop Med Hyg. 2018 Apr;98(4):1202-1208. doi: 10.4269/ajtmh.17-0382. Epub 2018 Feb 15.

24.

An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014-2015.

Feldstein LR, Rowhani-Rahbar A, Staples JE, Halloran ME, Ellis EM.

Am J Trop Med Hyg. 2018 Mar;98(3):845-848. doi: 10.4269/ajtmh.17-0799. Epub 2018 Feb 1.

25.

Simulations for designing and interpreting intervention trials in infectious diseases.

Halloran ME, Auranen K, Baird S, Basta NE, Bellan SE, Brookmeyer R, Cooper BS, DeGruttola V, Hughes JP, Lessler J, Lofgren ET, Longini IM, Onnela JP, Özler B, Seage GR, Smith TA, Vespignani A, Vynnycky E, Lipsitch M.

BMC Med. 2017 Dec 29;15(1):223. doi: 10.1186/s12916-017-0985-3.

26.

Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study.

Basta NE, Berthe A, Keita M, Onwuchekwa U, Tamboura B, Traore A, Hassan-King M, Manigart O, Nascimento M, Stuart JM, Trotter C, Blake J, Carr AD, Gray SJ, Newbold LS, Deng Y, Wolfson J, Halloran ME, Greenwood B, Borrow R, Sow SO.

J Infect. 2018 Feb;76(2):140-148. doi: 10.1016/j.jinf.2017.11.006. Epub 2017 Nov 29.

27.

Antibody-dependent enhancement of severe dengue disease in humans.

Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, Balmaseda A, Harris E.

Science. 2017 Nov 17;358(6365):929-932. doi: 10.1126/science.aan6836. Epub 2017 Nov 2.

28.

Reply to Aguiar and Stollenwerk.

Yang Y, Meng Y, Halloran ME, Longini IM Jr.

Clin Infect Dis. 2018 Feb 1;66(4):642. doi: 10.1093/cid/cix883. No abstract available.

29.

Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.

Yang Y, Meng Y, Halloran ME, Longini IM Jr.

Clin Infect Dis. 2018 Jan 6;66(2):178-184. doi: 10.1093/cid/cix766.

30.

Evaluation and comparison of predictive individual-level general surrogates.

Gabriel EE, Sachs MC, Halloran ME.

Biostatistics. 2018 Jul 1;19(3):307-324. doi: 10.1093/biostatistics/kxx037.

31.

Estimating population effects of vaccination using large, routinely collected data.

Halloran ME, Hudgens MG.

Stat Med. 2018 Jan 30;37(2):294-301. doi: 10.1002/sim.7392. Epub 2017 Jul 19.

32.

Zika virus evolution and spread in the Americas.

Metsky HC, Matranga CB, Wohl S, Schaffner SF, Freije CA, Winnicki SM, West K, Qu J, Baniecki ML, Gladden-Young A, Lin AE, Tomkins-Tinch CH, Ye SH, Park DJ, Luo CY, Barnes KG, Shah RR, Chak B, Barbosa-Lima G, Delatorre E, Vieira YR, Paul LM, Tan AL, Barcellona CM, Porcelli MC, Vasquez C, Cannons AC, Cone MR, Hogan KN, Kopp EW, Anzinger JJ, Garcia KF, Parham LA, Ramírez RMG, Montoya MCM, Rojas DP, Brown CM, Hennigan S, Sabina B, Scotland S, Gangavarapu K, Grubaugh ND, Oliveira G, Robles-Sikisaka R, Rambaut A, Gehrke L, Smole S, Halloran ME, Villar L, Mattar S, Lorenzana I, Cerbino-Neto J, Valim C, Degrave W, Bozza PT, Gnirke A, Andersen KG, Isern S, Michael SF, Bozza FA, Souza TML, Bosch I, Yozwiak NL, MacInnis BL, Sabeti PC.

Nature. 2017 Jun 15;546(7658):411-415. doi: 10.1038/nature22402. Epub 2017 May 24.

33.

Spread of Zika virus in the Americas.

Zhang Q, Sun K, Chinazzi M, Pastore Y Piontti A, Dean NE, Rojas DP, Merler S, Mistry D, Poletti P, Rossi L, Bray M, Halloran ME, Longini IM Jr, Vespignani A.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4334-E4343. doi: 10.1073/pnas.1620161114. Epub 2017 Apr 25.

34.

Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.

Zaman K, Sack DA, Neuzil KM, Yunus M, Moulton LH, Sugimoto JD, Fleming JA, Hossain I, Arifeen SE, Azim T, Rahman M, Lewis KDC, Feller AJ, Qadri F, Halloran ME, Cravioto A, Victor JC.

PLoS Med. 2017 Apr 18;14(4):e1002282. doi: 10.1371/journal.pmed.1002282. eCollection 2017 Apr.

35.

Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016.

Feldstein LR, Rowhani-Rahbar A, Staples JE, Weaver MR, Halloran ME, Ellis EM.

Emerg Infect Dis. 2017 Apr;23(4):673-676. doi: 10.3201/eid2304.161562.

36.

Dependent Happenings: A Recent Methodological Review.

Halloran ME, Hudgens MG.

Curr Epidemiol Rep. 2016 Dec;3(4):297-305. doi: 10.1007/s40471-016-0086-4. Epub 2016 Jul 28.

37.

Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design.

Schwartz LM, Halloran ME, Rowhani-Rahbar A, Neuzil KM, Victor JC.

Vaccine. 2017 Jan 3;35(1):184-190. doi: 10.1016/j.vaccine.2016.10.077. Epub 2016 Nov 18.

38.

Containing Ebola at the Source with Ring Vaccination.

Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore Y Piontti A, Dean NE, Putoto G, Carraro D, Longini IM Jr, Halloran ME, Vespignani A.

PLoS Negl Trop Dis. 2016 Nov 2;10(11):e0005093. doi: 10.1371/journal.pntd.0005093. eCollection 2016 Nov.

39.

PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH.

Koepke AA, Longini IM Jr, Halloran ME, Wakefield J, Minin VN.

Ann Appl Stat. 2016 Jun;10(2):575-595. Epub 2016 Jul 22.

40.

Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis.

Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr, Halloran ME, Vespignani A.

BMC Med. 2016 Sep 7;14(1):130. doi: 10.1186/s12916-016-0678-3.

41.

The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016.

Rojas DP, Dean NE, Yang Y, Kenah E, Quintero J, Tomasi S, Ramirez EL, Kelly Y, Castro C, Carrasquilla G, Halloran ME, Longini IM.

Euro Surveill. 2016 Jul 14;21(28). doi: 10.2807/1560-7917.ES.2016.21.28.30283.

42.

The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015.

Feldstein LR, Ellis EM, Rowhani-Rahbar A, Halloran ME, Ellis BR.

Am J Trop Med Hyg. 2016 Oct 5;95(4):885-889. doi: 10.4269/ajtmh.16-0288. Epub 2016 Jul 11.

43.

Projected Impact of Dengue Vaccination in Yucatán, Mexico.

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM.

PLoS Negl Trop Dis. 2016 May 26;10(5):e0004661. doi: 10.1371/journal.pntd.0004661. eCollection 2016 May.

44.

Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees.

Kenah E, Britton T, Halloran ME, Longini IM Jr.

PLoS Comput Biol. 2016 Apr 12;12(4):e1004869. doi: 10.1371/journal.pcbi.1004869. eCollection 2016 Apr.

45.

Comparing biomarkers as trial level general surrogates.

Gabriel EE, Daniels MJ, Halloran ME.

Biometrics. 2016 Dec;72(4):1046-1054. doi: 10.1111/biom.12513. Epub 2016 Apr 1.

46.

Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone.

Fang LQ, Yang Y, Jiang JF, Yao HW, Kargbo D, Li XL, Jiang BG, Kargbo B, Tong YG, Wang YW, Liu K, Kamara A, Dafae F, Kanu A, Jiang RR, Sun Y, Sun RX, Chen WJ, Ma MJ, Dean NE, Thomas H, Longini IM Jr, Halloran ME, Cao WC.

Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4488-93. doi: 10.1073/pnas.1518587113. Epub 2016 Mar 28.

47.

Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection.

Dean NE, Halloran ME, Yang Y, Longini IM.

Clin Infect Dis. 2016 May 15;62(10):1277-1286. doi: 10.1093/cid/ciw114. Epub 2016 Feb 29. Review.

48.

One versus two doses: What is the best use of vaccine in an influenza pandemic?

Matrajt L, Britton T, Halloran ME, Longini IM Jr.

Epidemics. 2015 Dec;13:17-27. doi: 10.1016/j.epidem.2015.06.001. Epub 2015 Jun 22.

49.

A Bayesian approach to estimating causal vaccine effects on binary post-infection outcomes.

Zhou J, Chu H, Hudgens MG, Halloran ME.

Stat Med. 2016 Jan 15;35(1):53-64. doi: 10.1002/sim.6573. Epub 2015 Jul 20.

50.

The dengue vaccine pipeline: Implications for the future of dengue control.

Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr.

Vaccine. 2015 Jun 26;33(29):3293-8. doi: 10.1016/j.vaccine.2015.05.010. Epub 2015 May 16. Review.

Supplemental Content

Loading ...
Support Center